<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03889938</url>
  </required_header>
  <id_info>
    <org_study_id>BMP</org_study_id>
    <nct_id>NCT03889938</nct_id>
  </id_info>
  <brief_title>Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis</brief_title>
  <official_title>Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Assess the level of lipid mediators in patients with psoriasis

        2. Assess the urinary level of biopyrins as New marker of oxidative stress in patients with
           psoriasis

        3. Correlate the serum level of bioactive lipid mediators and urinary level of biopyrins
           with Psoriasis Area and Severity Index
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psoriasis is acommon immune mediated inflammatory skin disorder of complex pathomechanisms
      which is generically conditioned and influenced by environmental factors
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the serum level of bioactive lipid mediators in patients with psoriasis</measure>
    <time_frame>1 month</time_frame>
    <description>Bioactive lipid mediators (LMs) are potent compounds reported to play a role in the development and resolution of inflammation.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Psoriasis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum and urinary assessment</intervention_name>
    <description>Assess bioactive lipid mediators in blood and biopyrins in urine</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with psoriasis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age from12 to 80 and both sex

        Exclusion Criteria:

          -  patients with other dermatological disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Shimaa Mahrous</last_name>
    <phone>01011845338</phone>
    <email>shimaamahrous9@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eman Kamal, Ass prof</last_name>
  </overall_contact_backup>
  <reference>
    <citation>Sorokin AV, Domenichiello AF, Dey AK, Yuan ZX, Goyal A, Rose SM, Playford MP, Ramsden CE, Mehta NN. Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood. J Invest Dermatol. 2018 Jul;138(7):1518-1528. doi: 10.1016/j.jid.2018.02.003. Epub 2018 Feb 15.</citation>
    <PMID>29454560</PMID>
  </reference>
  <reference>
    <citation>Bakry OA, El Hefnawy S, Mariee AH, El Gendy Y. Urinary Biopyrrins: A New Marker of Oxidative Stress in Psoriasis. Indian J Dermatol. 2016 Mar-Apr;61(2):169-73. doi: 10.4103/0019-5154.177756.</citation>
    <PMID>27057016</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 22, 2019</study_first_submitted>
  <study_first_submitted_qc>March 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>March 24, 2019</last_update_submitted>
  <last_update_submitted_qc>March 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shimaa Mahrous</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

